IMCD at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
IMCD brings 5 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its work centres on extended-release tablets, showing how HPMC grade, drug particle size and matrix weight shape release for drugs such as metformin and levetiracetam. Projects also test ready-to-use pre-emulsion concentrates for faster solubility gains.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
IMCD Rotterdam, Netherlands | |
Distributor of specialty chemicals and ingredients, including pharmaceutical excipients, backed by formulation application labs. | Poster Mon Oct 26 9:30am–10:30am Weight-Reduced Hydrophilic Matrix Strategy for Multi-Strength Metformin Hydrochloride Extended-Release Tablets USP Poster Mon Oct 26 10:30am–11:30am Excipient-Engineered Sustainable Development of Upadacitinib Hemihydrate Extended-Release Tablets by Direct Compression Poster Mon Oct 26 12:30pm–1:30pm Influence of API Particle Size and HPMC Concentration on the Release Performance of Gliclazide Tablets: A Formulation Development Study Using BCS Class II Model Drug Poster Mon Oct 26 1:30pm–2:30pm Influence of HPMC Molecular Weight on the Drug Release Mechanism of a Highly Water-Soluble Drug: A Comparative Study of Levetiracetam Extended-Release Matrix Tablets Poster Mon Oct 26 3:30pm–4:30pm Fast-Tracking Solubility and Bioavailability Enhancement with Ready-to-Use Pre-Emulsion Concentrates |
Instantly find 20 buyers from IMCD
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction